EP Patent

EP2358202B1 — Benzimidazole and aza-benzimidazole carboxamides

Assigned to Merck Sharp and Dohme LLC · Expires 2016-06-15 · 10y expired

What this patent protects

Patent listed against selumetinib-sulfate.

Drugs covered by this patent

selumetinib-sulfate (SELUMETINIB SULFATE)

Patent Metadata

Patent number: EP2358202B1
Jurisdiction: EP
Classification: —
Expires: 2016-06-15
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.